Asthma Study
Adults between 18-80 years of age who currently use Advair, Symbicort, Dulera, AirDuo, or Breo on a daily basis and continue to have asthma symptoms.
Chronic Refractory Cough (CRC) – Study #1
Adults 18 years of age or older with a diagnosis of unexplained chronic cough (Chronic Refractory Cough) for at least 1 year.
Chronic Refractory Cough (CRC) – Study #2
Adults 18 years of age or older with a diagnosis of unexplained chronic cough (Chronic Refractory Cough) for at least 1 year.
Chronic Obstructive Pulmonary Disease (COPD) Study #1
Current or former cigarette smokers between the ages of 40-80 who currently use daily inhalers to control symptoms related to chronic obstructive pulmonary disease (COPD). Eligible COPD participants include those that have had 1 or more breathing flare-up(s), in the last 12 months, that were treated with oral steroids and/or antibiotics and/or hospitalization.
Chronic Obstructive Pulmonary Disease (COPD) Study #2
This study is seeking current or former cigarette smokers over the age of 40 with suspected or diagnosis of chronic obstructive pulmonary disease (COPD). Only individuals currently using Spiriva on a daily basis for the past 3 months may be eligible.
FAQs
Get ready for your upcoming appointment by reviewing answers to these frequently asked questions.